Skip to content

Drug interactions

Octreotide + Rilpivirine

Severity: Moderate

Octreotide and Rilpivirine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rilpivirine at supratherapeutic doses prolongs the QT interval, and octreotide may contribute QT effects and bradycardia. The combination may modestly increase the risk of arrhythmia, particularly with other risk factors.

What this interaction means in plain words

Octreotide and Rilpivirine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Octreotide belongs to Endocrine; Rilpivirine belongs to Anti Virals.

Evidence level: Low

Why it happens

Additive QT interval prolongation through pharmacodynamic effects.

What to do

Obtain a baseline ECG in patients with cardiac risk factors and monitor periodically. Correct electrolyte abnormalities and avoid adding further QT-prolonging drugs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Octreotide and Rilpivirine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Octreotide with Rilpivirine?

MediHelp rates the interaction as moderate. Octreotide and Rilpivirine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rilpivirine at supratherapeutic doses prolongs the QT interval, and octreotide may contribute QT effects and bradycardia. The combination may modestly increase the risk of arrhythmia, particularly with other risk factors.

How serious is the interaction between Octreotide and Rilpivirine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG in patients with cardiac risk factors and monitor periodically. Correct electrolyte abnormalities and avoid adding further QT-prolonging drugs.

What other medicines interact with Octreotide?

MediHelp also lists interactions of Octreotide with, for example, Adagrasib, Amisulpride, Arsenic trioxide. The full list is on the Octreotide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in